TAVI: How to best predict postprocedural outcomes?

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Risk Prediction

Background:

• Transcatheter aortic valve implantation (TAVI) is a key treatment for aortic stenosis.
• Existing baseline risk scores, such as STS and EuroSCORE, have limitations in predicting long-term TAVI outcomes.
• Improved risk stratification is crucial for optimizing patient selection and postprocedural management.

Discussion:

• Baseline risk scores may not fully capture the complexity of TAVI patient outcomes.
• Incorporating postprocedural data offers a more dynamic and potentially accurate assessment.
• The ACEF-7 score, utilizing early postprocedural creatinine clearance, emerges as a significant predictor.

Key Insights:

• The ACEF-7 risk score, incorporating the lowest creatinine clearance within 7 days post-TAVI, predicts worse long-term outcomes.
• This novel score demonstrates superior predictive capability compared to traditional baseline scores.
• Early postprocedural renal function is a critical determinant of long-term TAVI success.

Outlook:

• The ACEF-7 score could enhance clinical decision-making for TAVI procedures.
• Further validation in diverse patient cohorts is warranted.
• Integrating postprocedural markers may refine risk models for structural heart interventions.